Skip to main content

facebook twitter google google | 44 Hudson Street New York, NY 10013 |

Blog

FDA Clears Freezing Fat for Reduction

Posted September 13, 2010 in Home, Minimally Invasive and Non-Invasive Fat Removal

Syd Coleman of New York City announces that the FDA has just cleared the exciting new non-invasive technology from Zeltiq, cryolipolysis, for the selective reduction of bulges on your body from small amounts of excess fat. Dr. Coleman has been successfully using the technology in his office at TriBeCa Plastic Surgery for over two years, and has written a paper on the safety and efficacy of Cryolipolysis.

Read More

CBS interviewed New York City Surgeon Sydney Coleman for Zeltiq Cryolipolysis

Posted June 22, 2010 in Media, Minimally Invasive and Non-Invasive Fat Removal

CBS News interviewed Sydney Coleman to discuss his experience with a non-invasive device by Zeltiq that reduces fat bulges. Dr. Syd Coleman was the lead author in a paper that demonstrated that cryolipolysis treatment can cause substantial reductions in subcutaneous fat volume and changes in the contour of the treated love handle without damage to the skin or underlying tissues.

Read More

Zeltiq Device Now Available in the Office of Sydney Coleman in New York City, NY

Posted October 21, 2009 in Home, Minimally Invasive and Non-Invasive Fat Removal

Dr. Syd Coleman was the lead author in a paper that demonstrated that cryolipolysis treatment can cause substantial reductions in subcutaneous fat volume and changes in the contour of the treated love handle without damage to the skin or underlying tissues. The Zeltiq device has not been approved by the FDA for the purposes discussed in the paper.

Read More

FDA Has Approved Zeltiq Device for Several Uses

Posted September 22, 2009 in Minimally Invasive and Non-Invasive Fat Removal

The FDA has approved the Zeltiq device in a 510(K) application. Dr. Syd Coleman was the lead author in a paper that demonstrated that cryolipolysis treatment can cause substantial reductions in subcutaneous fat volume and changes in the contour of the treated love handle without damage to the skin or underlying tissues. The Zeltiq device has not been approved by the FDA for the purposes discussed in the paper.

Read More